middle.news
OncoSil Raises $8M to Power German Trial and European Growth
11:12am on Tuesday 3rd of February, 2026 AEDT
•
Healthcare
Read Story
OncoSil Raises $8M to Power German Trial and European Growth
11:12am on Tuesday 3rd of February, 2026 AEDT
Key Points
Capital raise of $8 million via $6 million placement and $2 million entitlement offer
Strong backing from cornerstone investor Pengana and company directors
German G-BA clinical trial to start in first half of 2026 involving 40 hospitals
Expansion momentum in Spain, Italy, and Turkey with growing hospital adoption
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE